|
| Press Releases |
|
 |
|
| Tuesday, September 6, 2022 |
|
|
Yeahka (09923.HK) share price rises 4.45%, Major brokers grant "Buy" rating |
| Yeahka Limited ("Yeahka" or the "Company", Stock Code: 9923), a leading payment-based technology platform in China, increased by 4.45% and closed at HK$17.86 per share. Its share price climbed by about 30% in the past five trading days. more info >> |
|
|
移卡（09923.HK）涨4.45% 多家大行给予“买入”评级 |
中国领先的以支付为基础的科技平台——移卡有限公司（「移卡」或「公司」，股份代号：9923.HK）涨4.45%，报收于17.86港元/股。近五个交易日累计涨约30%。
more info >> |
|
|
移卡（09923.HK）漲4.45% 多家大行給予“買入”評級 |
| 中國領先的以支付爲基礎的科技平台——移卡有限公司（「移卡」或「公司」，股份代號：9923.HK）漲4.45%，報收於17.86港元/股。近五個交易日累計漲約30%。 more info >> |
|
| Friday, September 2, 2022 |
|
|
Jefferies maintains Buy rating on Yeahka (9923.HK) |
| Yeahka, the leading payment-based technology platform in China announced its 2022 interim results in late August. During the period, total revenue climbed 17.1% to RMB1,641.8 million, gross profit rose 52.1% to RMB529.3 million, and gross margin increased from 24.8% to 32.2%. more info >> |
|
| Tuesday, August 30, 2022 |
|
|
移卡公布2022年中期业绩 |
| 中国领先的以支付为基础的科技平台——移卡有限公司（“移卡”或“公司”，股份代号：9923.HK）欣然宣布截至2022年6月30日止六个月（“期内”或“2022年上半年”）中期业绩。 more info >> |
|
|
移卡公佈2022年中期業績 |
| 中國領先的以支付爲基礎的科技平台——移卡有限公司（「移卡」或「公司」，股份代號：9923.HK）欣然宣佈截至2022年6月30日止六個月（「期內」或「2022年上半年」）中期業績。 more info >> |
|
|
Yeahka Announces 2022 Interim Results |
| Yeahka Limited ("Yeahka" or the "Company", Stock Code: 9923), a leading payment-based technology platform in China, is pleased to announce the interim results for the six months ended 30 June 2022 (the "period" or "1H 2022"). more info >> |
|
| Tuesday, July 5, 2022 |
|
|
移卡成功發行於2027年到期約549.23百萬港元可轉換債券 |
| 中國領先的以支付為基礎的科技平台移卡有限公司（簡稱「移卡」或「公司」）（股份代號：09923.HK），今日欣然宣佈，公司已於2022年7月5日成功發行於2027年到期的約549.23百萬港元可轉換債券。 more info >> |
|
| Tuesday, March 29, 2022 |
|
|
移卡将于2022年3月31日公布2021全年业绩 已获13家头部券商积极覆盖 |
| 兴业证券首次覆盖移卡有限公司（简称「移卡」或「公司」）（股份代号：09923.HK），并给予移卡“增持”评级。 more info >> |
|
|
移卡將於2022年3月31日公佈2021全年業績 已獲13家頭部券商積極覆蓋 |
| 興業證券首次覆蓋移卡有限公司（簡稱「移卡」或「公司」）（股份代號：09923.HK），並給予移卡「增持」評級。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
CITIC Telecom CPC Wins Two Awards, Celebrating 'Innovation Never Stops' for 25 Years, recognizing Cybersecurity & Innovation Excellence
Feb 9, 2026 13:28 HKT/SGT
|
|
|
中信國際電訊CPC榮獲兩大獎項 慶祝創新不斷廿五載 彰顯網絡安全與持續創新實力
Feb 9, 2026 13:11 HKT/SGT
|
|
|
JCB Announces Collaboration with Resorts World Sentosa in Singapore
Feb 9, 2026 14:00 JST
|
|
|
中信国际电讯CPC荣获两大奖项 庆祝创新不断廿五载 彰显网络安全与持续创新实力
Feb 9, 2026 12:48 HKT/SGT
|
|
|
Anime Tokyo Station: "That Time I Got Reincarnated as a Slime" Special Exhibition, February 21 to May 24, 2026
Feb 9, 2026 11:00 JST
|
|
|
playX Secures Industry-Leading Player Protection Through Landmark Insurance Partnership with Great American Insurance Group
Feb 8, 2026 23:30: JST
|
|
|
playX Secures Industry-Leading Player Protection Through Landmark Insurance Partnership with Great American Insurance Group
Feb 8, 2026 23:30 HKT/SGT
|
|
|
Mr Liu Xiaojun, on behalf of Fufeng Group, has fully completed the acquisition of Viva World Trade, Inc.
Feb 7, 2026 05:45 HKT/SGT
|
|
|
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets
Feb 6, 2026 17:45 HKT/SGT
|
|
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 6, 2026 17:01 HKT/SGT
|
|
|
歌禮製藥-B（01672）獲新加坡政府投資公司首次入股 涉資約1億美元
Feb 6, 2026 16:56 HKT/SGT
|
|
|
歌礼制药-B（01672）获新加坡政府投资公司首次入股 涉资约1亿美元
Feb 6, 2026 16:50 HKT/SGT
|
|
|
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization
Feb 6, 2026 16:34 HKT/SGT
|
|
|
トヨタ、役員人事を発表
Feb 6, 2026 16:00: JST
|
|
|
牧原股份港股上市：全球生豬养殖龍頭 價值成長兼具
Feb 6, 2026 15:08 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
